Subgroup analyses in trial reports comparing percutaneous coronary intervention with coronary artery bypass surgery

JAMA

Volumn 310, Issue 19, 2013, Pages 2097-2098

  Head, Stuart J ^a   Kaul, Sanjay ^b   Tijssen, Jan G P ^c   Serruys, Patrick W ^a   Kappetein, A Pieter ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HUMAN; INTERMETHOD COMPARISON; MEDICAL RESEARCH; MEDICAL SERVICE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TOTAL QUALITY MANAGEMENT; TREATMENT RESPONSE;

EID: 84887932697     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.281630     Document Type: Article

References (6)

1. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000;355(9209):1064-1069.
2. Sun X, Briel M, Busse JW, et al. Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ. 2012;344:e1553.
3. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine-reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357(21):2189-2194.
4. Kolh P, Wijns W, Danchin N, et al Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI). Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2010;38(suppl):S1-S52.
5. Pocock S, Calvo G, Marrugat J, et al. International differences in treatment effect: do they really exist and why? Eur Heart J. 2013;34(24):1846-1852.
6. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.